The long-lasting effects of leprosy are still evident in various parts of the world. This book details the personal experiences of people in Fiji, New Caledonia, Samoa, Tonga and Vanuatu, the majority of whom contracted leprosy as children. It recounts how the victims were subject to prolonged isolation in various leprosaria as the first effective cure for leprosy only became available after 1949. Oral histories are utilized and verbatim extracts demonstrate the level of stigma experienced by these young people. Topics covered include the exact nature of the diagnosis, removal from one's family, the experience of isolation, and the reaction of family and villages upon the individual's return to community life.

It is now widely accepted that there are important links between inactivity and lifestyle-related chronic diseases, and that exercise can bring tangible therapeutic benefits to people with long-term chronic conditions. Exercise and Chronic Disease: An Evidence-Based Approach offers the most up-to-date survey currently available of the scientific and clinical evidence underlying the effects of exercise in relation to functional outcomes, disease-specific health-related outcomes and quality of life in patients with chronic disease conditions.

Drawing on data from randomized controlled trials and observational evidence, and written by a team of leading international researchers and medical and health practitioners, the book explores the evidence across a wide range of chronic diseases, including:

• cancer
• heart disease
• stroke
• diabetes
• parkinson's disease
• multiple sclerosis
• asthma.

Each chapter addresses the frequency, intensity, duration and modality of exercise that might be employed as an intervention for each condition and, importantly, assesses the impact of exercise interventions in relation to outcomes that reflect tangible benefits to patients. No other book on this subject places the patient and the evidence directly at the heart of the study, and therefore this book will be essential reading for all exercise scientists, health scientists and medical professionals looking to develop their knowledge and professional practice.

It is now widely accepted that there are important links between inactivity and lifestyle-related chronic diseases, and that exercise can bring tangible therapeutic benefits to people with long-term chronic conditions. Exercise and Chronic Disease: An Evidence-Based Approach offers the most up-to-date survey currently available of the scientific and clinical evidence underlying the effects of exercise in relation to functional outcomes, disease-specific health-related outcomes and quality of life in patients with chronic disease conditions. Drawing on data from randomized controlled trials and observational evidence, and written by a team of leading international researchers and medical and health practitioners, the book explores the evidence across a wide range of chronic diseases, including: cancer heart disease stroke diabetes parkinson's disease multiple sclerosis asthma. Each chapter addresses the frequency, intensity, duration and modality of exercise that might be employed as an intervention for each condition and, importantly, assesses the impact of exercise interventions in relation to outcomes that reflect tangible benefits to patients. No other book on this subject places the patient and the evidence directly at the heart of the study, and therefore this book will be essential reading for all exercise scientists, health scientists and medical professionals looking to develop their knowledge and professional practice.

Motivational Perspectives on Chronic Pain is one of the first volumes to present a cohesive account of the adaptation to chronic pain from a motivational perspective. Contributing authors from diverse areas of pain research offer comprehensive summaries of the concepts, findings, and applied methodologies that converge on the role of goals and goal-related cognitive processes, self-regulatory support mechanisms, contextual forces, and emotionality as they influence (and are influenced by) the experience of chronic pain. This volume provides readers with an up-to-date compendium of cutting-edge research and interventions that collectively illustrate the utility of viewing chronic pain neither as a "disease" nor an imposed lifestyle, but as the emergent and potentially flexible product of a complex transactional system that is bounded by both sociocultural factors and by biogenetic and neural moderating forces. Within its pages, chapters capture the vibrancy of current theory, research, and practice while pointing toward unexplored new directions. Among the important topics addressed by this distinguished group of authors include: the nature and relevance of control systems, the role of neural mechanisms on pain processing, the influence positive and negative emotion regulation play on pain management, the impact of learning and conditioning, and the often neglected influence of interpersonal processes on adjustment to chronic pain.

Targeting the key active elements in the mechanism and application of apoptosis and its therapeutic implications, Apoptosis: Modern Insights into Disease from Molecules to Man covers apoptosis from A to Z. Comprehensive in scope, it explores a wide range of topics including various cancers, asthma, and multiple sclerosis as well as alcohol induced liver disease, chronic back pain, and cardiovascular health. With 40 chapters written by highly respected authorities, this single source reference provides researchers and scientists with the foundation they need.

This issue, guest edited by Alimuddin Zumla and H. Simon Schaaf, focuses on the topic of Tuberculosis. Articles include: Global Burden and Epidemiology of Tuberculosis; Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in the West. Europe and the United States: Epidemiology, Surveillance, and Control; Multidrug- and Extensively Drug-resistant Tuberculosis in Africa and South America: Epidemiology, Diagnosis and Management in Adults and Children; Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings; Novel and Improved Technologies for Tuberculosis Diagnosis: Progress and Challenges; Advances in Imaging Chest Tuberculosis: Blurring of Differences Between Children and Adults; Update on Tuberculosis of the Central Nervous System: Pathogenesis, Diagnosis, and Treatment; Advances in Immunotherapy for Tuberculosis Treatment, and more!

This completely revised and updated second edition to integrates the many new technologies and insights now available for the diagnosis of genetic diseases. The authors use such methodologies as PCR optimization dosage analysis, mutation scanning, and quantitative fluorescent PCR for aneuploidy analysis, Neurofibromatosis type 1, and Duchenne muscular dystrophy. These largely generic methodologies may be adapted to most genetic conditions for which a molecular diagnosis is relevant, no matter how frequent or rare their incidence. Molecular Diagnosis of Genetic Diseases, Second Edition offers diagnostic molecular geneticists a unique opportunity to sharpen their scientific skills in the design of assays, their execution, and their interpretation.

Call it a remnant of our Victorian past, but sexual concerns lag behind other aspects of health, both in the training of physicians and therapists and in the way they impart this knowledge to clients. But as sexuality gains recognition as crucial to one's quality of life, evidence-based methods of understanding and discussing sex are imperative-and not only in treating pathology. Sexual Medicine in Clinical Practice provides framework, rationale, and strategies for both approaching sexual problems and addressing patients' questions about sexual health, behavior, and relationships. Analyzing sexuality along three dimensions-attachment, reproduction, and desire-this concise manual offers a biopsychosocial lifespan model readily translatable into clinical work. This "syndyastic" framework integrates attachment and relational theory to reinforce the bond between intimacy and connectedness, and models nonjudgmental approaches to disorders of sexual function, maturity, preference, and behavior. The authors' salutogenic rather than pathogenic focus lets clients become major players in their own healing, and the therapist or doctor serve as expert and guide. Among the topics covered: The communicative function of sexuality. The spectrum of sexual disorders. Principles of diagnostics in sexual medicine. Disease-centered versus client-centered aspects of sexual therapy. Therapeutic approaches for sexual traumatization. New challenges, including preventing child sexual abuse and online sex crime. Plus case studies, interdisciplinary references, and ethical issues. A timely, perspective- and practice-altering volume, Sexual Medicine in Clinical Practice is essential reading for family and primary care physicians, family and sex therapists, health psychologists, and psychiatrists.

From an acclaimed author in the field, this is a compelling study of the origins and history of the disease commonly seen as afflicting young unmarried girls. Understanding of the condition turned puberty and virginity into medical conditions, and Helen King stresses the continuity of this disease through history, depsite enormous shifts in medical understanding and technonologies, and drawing parallels with the modern illness of anorexia. Examining its roots in the classical tradition all the way through to its extraordinary survival into the 1920s, this study asks a number of questions about the nature of the disease itself and the relationship between illness, body images and what we should call'normal' behaviour. This is a fascinating and clear account which will prove invaluable not just to students of classical studies, but will be of interest to medical professionals also

Andrology is the fastest growing subspecialty in urology and has recently achieved remarkable advances in the understanding of the erectile mechanism and in reproductive medicine. Male Infertility and Sexual Dysfunction presents all the current avenues of treatment with emphasis on multidisciplinary considerations. Chapters are written by select international authorities presenting indepth coverage of their areas of expertise. Each topic will cover the background, anatomy, physiology, diagnosis, classification, and treatment (medical and/or surgical). Part I focuses on the study of male infertility and includes discussions of the basic sciences, office evaluation, laboratory and imaging techniques, and the use of testicular biopsy. This is followed by specialized chapters dealing with immunologic infertility, genital inflammation, reactive oxygen species, medical management, sperm processing and preventive adolescent andrology. Part II reflects a more diverse format in the coverage of sexual dysfunction and includes discussions of androgen insufficiency, nocturnal penile tumescence studies, neurotransmission, penile neurology, premature ejaculation, psychogenic impotence and the latest medical, noninvasive and surgical treatments.

Syncope represents a multidisciplinary issue in medicine, often involving cardiologists, neurologists, emergency medicine specialists, general practitioners , geriatricians and other clinicians. However, terminology, methodology and guidelines differ making the issue more complex. The Editors of this book present a thorough multidisciplinary review of the topic. Guideline-based, they have assembled a team of key opinion leaders in the study and management of syncope. The first section of the book discusses the scientific basis behind the diagnosis and management of syncope going into detail regarding the pathways leading to syncope symptoms and the pathology behind them. The second section of the book then takes a more practical approach defining the practice of syncope management and including a number of case histories explaining the pearls and pitfalls of the current guidelines.

Morphological and functional studies revealed a complex system of primary sensory neurons which parallels the autonomic nervous system not only in its extent, but probably also in its significance. Neuropeptides released from activated nociceptive afferent nerves play a pivotal role in inflammatory reactions and pain, significantly modulate cardiac, vascular, respiratory, gastrointestinal and immune functions and influence the protective, restorative and trophic functions of somatic and visceral tissues. Several chapters of the book deal with the therapeutic potential of a new class of putative pain relieving agents acting through TRPV1, the capsaicin/vanilloid receptor, a specific ion channel which transmits pain.
*Neurogenic inflammation in historical perspective
*Cardiac protection by nociceptive afferents
*Molecular mechanisms of nociception
*Sensory mechanisms in migraine pathophysiology
*Vagal signalling of visceral inflammation
*Neurogenic mechanisms in arthritis
*Therapeutic implications of vanilloid-type compounds

Pharmacogenetics is becoming increasingly relevant in the diagnosis, treatment, and recovery of cancer patients. A major problem facing oncologists is the outstanding varied efficacy of treatment. Promising advances in pharmacogenetics have allowed the development of effective agents which will enable personalized cancer chemotherapy to become routine for the clinical practice.

Written by experts in the field and combining information that is unable to be found in a single source volume, Pharmacogenetics of Breast Cancer

• combines a complete overview of pharmacogenetics and how it relates to breast oncology for diagnosis, treatment, and the recovery of patients using an individualized therapy model
• is the first single source reference demonstrating the application of pharmacogenetics in the care of breast cancer patients
• enables physicians a coherent interpretation of the emerging science of pharmacogenetics, aiding them to incorporate individual therapies in their own practice
• gives practical guidance on various forms of specimen collection, tissue selection, and handling procedures

Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Cancer Vaccines: Challenges and Opportunities in Translation: Critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential Discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy Presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer Reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them

Written with a broader perspective and knowledge, Cancer Supportive Care: Advances in Therapeutic Strategies presents state-of-the-art management options for the full range of symptoms, toxicities, and complications experienced by cancer patients. In addition to "bread and butter" topics such as pain control and nausea and vomiting, the book contains unique, ground-breaking discussions of symptom measurement, the role of growth factors, and late effects and cancer survivorship. Written by key opinion leaders in the field, Cancer Supportive Care: Advances in Therapeutic Strategies: assembles and synthesizes state-of-the-art information into one convenient resource, helping busy clinicians learn the most effective supportive care strategies available discusses emerging therapies and approaches covers topics not included in other cancer supportive care books, such as measurement of symptoms, growth factors, thromboembolism, skeletal complications, fatigue, the elderly cancer patient, cancer survivorship, and alternative and integrative therapies

Multiple myeloma is the second most prevalent hematological malignancy, with over 55,000 new cases diagnosed each year. This exciting new text, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesizes the latest studies on translational therapies and clearly explains the impact of molecular pathogenesis, biology, and prognostic factors on the diagnosis, prognosis, and individualization of treatment and the development of novel therapeutic options for patients with myeloma. Moving from the bench to the bedside to the forefront of therapeutic development, this source: helps clinicians and researchers effectively deploy therapeutic strategies into clinical practice reflects trends in the use of agents which target both the tumor cell and its bone marrow microenvironment to overcome resistance to conventional therapies considers the critical role of the bone marrow microenvironment in the regulation of growth, survival, and homing of multiple myeloma discusses novel therapies in phase I and phase II trials, focusing specifically on therapeutic options for patients with newly diagnosed or relapsed/refractory multiple myeloma addresses novel therapies for other plasma cell disorders, and provides the framework for the design of next generation agents and combination therapies covers the entire scope of translational work in multiple myeloma, from advances in molecular pathogenesis, to prognostic factors, immunotherapy, and new options for newly diagnosed and relapsed multiple myeloma patients

If you had a trillion dollars and a year to spend it for the good of the world and the advancement of science, what would you do? It's an unimaginably large sum, yet it's only around one per cent of world GDP, and about the valuation of Google, Microsoft or Amazon. It's a much smaller sum than the world found to bail out its banks in 2008 or deal with Covid-19. But what could you achieve with $1 trillion? You could solve the problem of the pandemic, for one, and eradicate malaria, and maybe cure all disease. You could end global poverty. You could settle on the Moon and explore the solar system. You could build a massive particle collider to probe the nature of reality like never before. You could build quantum computers, develop artificial intelligence, or increase human lifespan. You could even create a new life form. Or how about transitioning the world to clean energy? Or preserving the rainforests, or saving all endangered species? Maybe you could refreeze the melting Arctic, launch a new sustainable agricultural revolution, and reverse climate change? How to Spend a Trillion Dollars is the ultimate thought experiment but it is also a call to arms: these are all things we could do, if we put our minds to it - and our money.

In this issue of Critical Care Clinics, guest editors Drs. Robert M. Kliegman and Brett J. Bordini bring their considerable expertise to the topic of Undiagnosed and Rare Diseases in Critical Care. Top experts in the field cover key topics such as critical genetic arrhythmia disorders, uncommon causes of rhabdomyolysis, status epilepsy syndromes, autoimmune encephalitis, rapid-onset paralysis and weakness, and more. Contains 17 relevant, practice-oriented topics including understanding cognitive diagnostic errors in the ICU; rapid WES/WGS in the ICU; diagnostic time-outs to improve diagnosis; when "sepsis" is not sepsis: MAS, HLH, malignancies and other sepsis mimics; all that wheezes is not asthma or bronchiolitis; and more. Provides in-depth clinical reviews on undiagnosed and rare diseases in critical care, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Considering the impact of translational breakthroughs on the early detection, diagnosis, prevention, and treatment of breast cancer, this all-encompassing guide collects cutting-edge research on the most promising strategies and agents likely to impact the management and long-term outcomes of women with breast cancer. This book will provide current information on rapidly evolving translational therapies, as well as improved strategies for the selection of patients for these treatments.

Emphasizing new and emerging therapies in each chapter, this reference provides essential information for clinicians to provide accurate diagnoses and select the most appropriate treatment regimens for patients with primary and metastatic brain tumors and neurological complications of cancer. Edited by a leading cast of authorities on the topic-including the Chief and Associate Editors of the Journal of Neuro-oncology-this easily-accessible guide reviews the epidemiology, identification, and management of brain tumors while exploring the latest advances in this increasingly diverse field.

Scientists have reached a critical point in the development of new therapies for prostate cancer. The information gleaned from the Human Genome Project, alongside the emergence of new technologies for the use of genetic data has expanded the physician's understanding of disease progression and widened his armamentarium for prostate cancer prevention and control. This expertly-written reference thoroughly analyzes the scientific principles and methodologies behind the most recent translational therapies and provides the necessary context, data, and studies for practitioners to select appropriate candidates for treatment and effectively apply new therapies in clinical practice.

This book, besides reviewing basic and clinical aspects of Behcet's disease, covers the latest findings, including genetic studies and treatment with biologics for the disease. Although the cause of Behcet's disease is still unknown, it is well known that genetic factors, such as HLA-B51, are involved in its development. Recently, novel susceptibility loci including IL10, IL23R-IL12RB2, and endoplasmic reticulum aminopeptidase 1 have been identified, providing new insights into the pathogenesis of the disease. In addition to basic research, the beneficial efficacy of anti-TNF-alpha monoclonal antibodies has also been suggested for not only uveitis associated with the disease but also other subtypes of the disease such as entero-, vasculo-, and neuro- Behcet's disease. Behcet's Disease: From Genetics to Therapies provides essential information both for basic researchers working in the fields of immunology, inflammation, and genetics, and for clinical physicians who are interested in Behcet's disease, such as ophthalmologists, rheumatologists, dermatologists, gastroenterologists, neurologists, and vascular surgeons.